Skip to content
Clinical Trials – home

Tebipenem Pivoxil Hydrobromide: A New Antibiotic for Patients

0 / 1
trials open to patients / all trials
9+
Countries

In short

Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) is an innovative oral antibiotic being studied in various clinical trials. This article summarizes key findings from these trials, exploring its potential use in treating infections, its effects on the body, and how it interacts with other medications. The research aims to establish the safety, effectiveness, and optimal dosing of this new drug across different patient groups.

At a glance

Drug Name
Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr)
Drug Class
Carbapenem antibiotic
Administration
Oral (tablets)
Dosage Range
300 mg to 600 mg, typically every 8 hours
Main Study Areas
Tissue penetration, pharmacokinetics, safety, bioequivalence, drug interactions
Patient Groups
Healthy volunteers, diabetic patients with wound infections, patients with varying degrees of renal function
Key Measurements
Drug concentration in blood and tissues, QT interval changes, adverse events
Potential Applications
Treatment of various bacterial infections, including complicated urinary tract infections and acute pyelonephritis

What is Tebipenem Pivoxil Hydrobromide?

Tebipenem Pivoxil Hydrobromide, also known as TBPM-PI-HBr or SPR994, is a new antibiotic medication being developed for treating various infections. It belongs to a class of antibiotics called carbapenems, which are known for their broad-spectrum activity against many types of bacteria. What makes Tebipenem unique is that it can be taken orally, whereas most other carbapenem antibiotics need to be given intravenously (through a vein).

How Does Tebipenem Work?

Tebipenem works by interfering with the cell wall formation of bacteria. This action prevents bacteria from growing and multiplying, ultimately leading to their death. As a broad-spectrum antibiotic, it can target a wide range of bacteria, including those that may be resistant to other types of antibiotics.

What Conditions Does Tebipenem Treat?

Based on the clinical trials information, Tebipenem is being studied for the treatment of several conditions:

  • Complicated Urinary Tract Infections (cUTIs): These are urinary tract infections that are more difficult to treat, often due to underlying conditions or resistant bacteria.
  • Acute Bacterial Skin and Skin Structure Infections (ABSSSI): These are serious skin infections that often require antibiotic treatment.
  • Diabetic Foot Infections: These are infections that occur in the feet of people with diabetes, which can be particularly challenging to treat.

How is Tebipenem Administered?

Tebipenem Pivoxil Hydrobromide is administered orally in tablet form. In the clinical trials, doses ranged from 300 mg to 600 mg, taken every 8 hours. The exact dosage and duration of treatment would be determined by a healthcare provider based on the specific infection being treated and other individual factors.

Clinical Studies on Tebipenem

Several clinical trials are being conducted to evaluate Tebipenem's effectiveness and safety:

  • Tissue Penetration Study: This study is looking at how well Tebipenem penetrates into the soft tissues of patients with diabetic foot infections compared to healthy volunteers.
  • Renal Impairment Study: This study is evaluating how Tebipenem behaves in the body of people with various degrees of kidney function, including those on dialysis.
  • Bioequivalence Study: This study is comparing different tablet formulations of Tebipenem to ensure they deliver the same amount of medication to the body.
  • QT Interval Study: This study is assessing whether Tebipenem affects heart rhythm, specifically the QT interval on an electrocardiogram (ECG).
  • Drug Interaction Studies: These studies are looking at how Tebipenem interacts with other medications, such as antacids and omeprazole (a medication used to reduce stomach acid).

Safety Profile and Side Effects

As Tebipenem is still in clinical trials, its full safety profile is not yet established. However, the studies are closely monitoring for any adverse events (side effects). Common side effects of antibiotics can include gastrointestinal symptoms (like nausea or diarrhea), headache, and skin rashes. More serious side effects are also being monitored, including effects on heart rhythm and kidney function.

Special Considerations for Tebipenem Use

Several factors are being studied that may affect how Tebipenem is used:

  • Kidney Function: People with reduced kidney function may need dose adjustments, as the kidneys play a role in eliminating the drug from the body.
  • Food Effects: Studies are looking at whether taking Tebipenem with food affects how the body absorbs the medication.
  • Drug Interactions: The potential for Tebipenem to interact with other medications, particularly antacids and acid-reducing drugs, is being investigated.

Questions people often ask

Conditions where Tebipenem Pivoxil Hydrobromide is being studied

Each condition opens its own overview and trial list

Trials with Tebipenem Pivoxil Hydrobromide

Recruiting trials first

See all 1 →
Quick filters
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.